Publikationsliste Prof. Dr. Heinz Grunze
A) Erst/Letzt-Autorenschaft (PubMed gelistet). 1
B) Co-Autorenschaft (PubMed gelistet). 12
C) Sonstige publizierte Arbeiten (PubMed gelisted). 26
1.Erst/Letzt-Autorenschaft. 26
E) Audiovisuelle Materialien. 35
|
A) Erst/Letztautorenschaften |
83 Publikationen |
|
B) Co-Autorenschaften |
101 Publikationen |
|
C) sonstige publizierte Arbeiten 1. Erst/Letztautorenschaft 2. Co-Autorenschaft |
29 Publikationen 10 Publikationen |
|
D) Buchartikel 1. Monographien 2. Beiträge 3. Wiss. Übersetzungen |
5 Publikationen 50 Publikationen 1 Publikation |
|
E) Audiovisuelle Materialien |
1 didaktische DVD |
Assessment of the efficacy and safety of eslicarbazepine acetate in acute mania and prevention of recurrence: Experience from multicentre, double-blind, randomised phase II clinical studies in patients with bipolar disorder.
Grunze H, Kotlik E, Costa R, Nunes T, Falcão A, Almeida L, Soares-da-Silva P.
Journal of Affective disorders 2015;174:70-82
PMID: 25484179
Stimulants for Treating Bipolar Disorder: Pro and Con
Grunze H
Harvard Review of Psychiatry 2014; 22 (6): 358–362
PMID: 25377610
Clinical decision making in the treatment of mixed states.
Grunze H, Azorin JM.
World J Biol Psychiatry. 2014 Jul;15(5):355-68.
PMID: 24824425.
Polypharmacy and bipolar disorder: what's personality got to do with it?
Sachs GS, Peters AT, Sylvia L, Grunze H.
nt J Neuropsychopharmacol. 2014 Jul;17(7):1053-61
PMID: 24067291.
Comparably high retention and low relapse rates in different subpopulations of bipolar patients in a German non-interventional study.
Kraemer S, Minarzyk A, Eppendorfer S, Henneges C, Hundemer HP, Wilhelm S, Grunze H.
BMC Psychiatry. 2013 Jul 17;13(1):193.
PMID: 23866017
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder.
Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller HJ, Kasper S; WFSBP Task Force on Treatment Guidelines for Bipolar Disorders.
World J Biol Psychiatry. 2013 Apr;14(3):154-219.
PMID: 23480132.
Sind atypische Antipsychotika Mittel erster Wahl bei bipolaren Storungen? Pro.
Grunze H.
Nervenarzt. 2012 Sep;83(9):1190-1.
PMID: 22911320.
Interpreting magnetic resonance imaging findings in bipolar disorder.
Cousins DA, Grunze H.
CNS Neurosci Ther. 2012 Mar;18(3):201-7.
PMID: 22449107
At the edge of the bipolar spectrum: primacy of affective over psychotic symptoms or vice versa?
Grunze H.
World Psychiatry. 2011 Oct;10(3):197-8.
PMID: 21991277
Quetiapine is effective in the treatment of adults in the acute phase of bipolar depression.
Grunze HC.
Evid Based Ment Health. 2010 Aug;13(3):88.
PMID: 20682828.
Anticonvulsants in bipolar disorder.
Grunze HC.
J Ment Health. 2010 Apr;19(2):127-41.
PMID: 20433321.
Akut- und Langzeittherapie der bipolaren Depressionen
Grunze H, Dargel S.
Nervenarzt. 2010 May;81(5):539-48.
PMID: 20386876.
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression.
Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller HJ, Kasper S; WFSBP Task Force On Treatment Guidelines For Bipolar Disorders.
World J Biol Psychiatry. 2010 Mar;11(2):81-109.
PMID: 20148751.
What works for delirious catatonic mania?
Vasudev K, Grunze H.
BMJ Case Rep. 2010 Jul 15;2010.
PMID: 22752702.
Cognitive functioning in euthymic bipolar I and bipolar II patients.
Dittmann S, Hennig-Fast K, Gerber S, Seemüller F, Riedel M, Emanuel Severus W, Langosch J, Engel RR, Möller HJ, Grunze HC.
Bipolar Disord. 2008 Dec;10(8):877-87.
PMID: 19594503.
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania.
Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, Kasper S.
World J Biol Psychiatry. 2009;10(2):85-116.
PMID: 19347775.
Die Bedeutung von Dopaminagonisten in der Behandlung der Depression.
Clausius N, Born C, Grunze H.
Neuropsychiatr. 2009;23(1):15-25.
PMID: 19272288.
Switching, induction of rapid cycling, and increased suicidality with antidepressants in bipolar patients: fact or overinterpretation?
Grunze HC.
CNS Spectr. 2008 Sep;13(9):790-5.
PMID: 18849898.
Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate.
Langosch JM, Drieling T, Biedermann NC, Born C, Sasse J, Bauer H, Walden J, Bauer M, Grunze H.
J Clin Psychopharmacol. 2008 Oct;28(5):555-60.
PMID: 18794653.
Lamotrigine in bipolar disorder: results of a mirror-image evaluation using the NIMHLifechart-Methodology.
Born C, Bernhard B, Dittmann S, Seemüller F, Grunze H.
J Affect Disord. 2009 May;115(1-2):241-5.
PMID: 18775569.
The effectiveness of anticonvulsants in psychiatric disorders.
Grunze HC.
Dialogues Clin Neurosci. 2008;10(1):77-89.
PMID: 18472486
Antiepileptika in der Therapie bipolarer Störungen
Grunze H.
Neuropsychiatr. 2007;21(2):110-20.
PMID: 17640497
Quetiapine for the continuation treatment of bipolar depression: naturalistic prospective case series from the Stanley Bipolar Treatment Network.
Suppes T, Kelly DI, Keck PE Jr, McElroy SL, Altshuler LL, Mintz J, Frye MA, Nolen WA, Luckenbaugh DA, Post RM, Leverich GS, Kupka RW, Grunze H.
Int Clin Psychopharmacol.2007 Nov;22(6):376-81.
PMID: 17917557.
Klinischer Stellenwert der Valproat-Therapie bei bipolaren Störungen.
Grunze H, Adli M, Bauer M, Berger M, Bergmann A, Bräunig P, Bschor T, Falkai P, Gastpar M, Greil W, Kasper S, Krüger S, Laux G, Müller WE, Naber D, Walden J.
Fortschr Neurol Psychiatr. 2007 Apr;75(4):220-35.
PMID: 17427043.
A 2-year, open-label pilot study of adjunctive chromium in patients with treatment-resistant rapid-cycling bipolar disorder.
Amann BL, Mergl R, Vieta E, Born C, Hermisson I, Seemueller F, Dittmann S, Grunze H.
J Clin Psychopharmacol. 2007 Feb;27(1):104-6.
PMID: 17224731.
New findings from the Bipolar Collaborative Network: clinical implications for therapeutics.
Post RM, Altshuler LL, Frye MA, Suppes T, McElroy S, Keck PE Jr, Leverich GS, Kupka R, Nolen WA, Grunze H.
Curr Psychiatry Rep. 2006 Dec;8(6):489-97
PMID: 17162830.
Influence of sub-syndromal symptoms after remission from manic or mixed episodes.
Tohen M, Bowden CL, Calabrese JR, Lin D, Forrester TD, Sachs GS, Koukopoulos A, Yatham L, Grunze H.
Br J Psychiatry. 2006 Dec;189:515-9.
PMID: 17139035.
An exploratory open trial on safety and efficacy of the anticonvulsant retigabine in acute manic
patients.
Amann B, Sterr A, Vieta E, Stampfer R, Walden J, Grunze H.
J Clin Psychopharmacol. 2006 Oct;26(5):534-6.
PMID: 16974202.
Ergenyl chronosphere bei Bipolaren Störungen
Grunze H.
Krankenpfl J. 2005;43(7-10):213.
PMID: 16515285.
A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities.
Rujescu D, Bender A, Keck M, Hartmann AM, Ohl F, Raeder H, Giegling I, Genius J, McCarley RW, Möller HJ, Grunze H.
Biol Psychiatry. 2006 Apr 15;59(8):721-9. Epub 2006 Jan 19.
PMID: 16427029.
Impact of cognitive-psychoeducational interventions in bipolar patients and their relatives.
Bernhard B, Schaub A, Kümmler P, Dittmann S, Severus E, Seemüller F, Born C, Forsthoff A, Licht RW, Grunze H.
Eur Psychiatry. 2006 Mar;21(2):81-6. Epub 2005 Dec 27.
PMID: 16380236.
Suizidalität und Internet. Gefahren durch neue Medien
Forsthoff A, Hummel B, Möller HJ, Grunze H.
Nervenarzt. 2006 Mar;77(3):343-5.
PMID: 16205877.
Zotepine loading in acute and severely manic patients: a pilot study.
Amann B, Sterr A, Mergl R, Dittmann S, Seemüller F, Dobmeier M, Orth M, Schaefer M, Grunze H.
Bipolar Disord. 2005 Oct;7(5):471-6
PMID: 16176441.
The safety and tolerability of atypical antipsychotics in bipolar disorder.
Seemüller F, Forsthoff A, Dittmann S, Born C, Bernhard B, Severus WE, Grunze H.
Expert Opin Drug Saf. 2005 Sep;4(5):849-68.
PMID: 16111448.
Newer prophylactic agents for bipolar disorder and their influence on suicidality.
Born C, Dittmann S, Post RM, Grunze H.
Arch Suicide Res. 2005;9(3):301-6.
PMID: 16020172.
Preliminary observations on the effectiveness of levetiracetam in the open adjunctive treatment of refractory bipolar disorder.
Post RM, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE Jr, Leverich GS, Kupka R, Nolen WA, Luckenbaugh DA, Walden J, Grunze H.
J Clin Psychiatry. 2005 Mar;66(3):370-4.
PMID: 15766304.
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment.
Grunze H, Kasper S, Goodwin G, Bowden C, Möller HJ; WFSBP Task Force on Treatment Guidelines for Bipolar Disorders.
World J Biol Psychiatry. 2004 Jul;5(3):120-35.
PMID: 15346536.
Jährliche Krankheitskosten bipolarer Störungen in Deutschland.
Runge C, Grunze H.
Nervenarzt. 2004 Sep;75(9):896-903.
PMID: 14999464.
Olanzapin (Zyprexa)--zuverlässig in Akuttherapie, Ruckfallschutz und bei der langfristigen Stimmungsstabilisierung.
Grunze H
Krankenpfl J. 2003;41(10-12):225.
PMID: 14746204.
Problemorientiertes Lernen im Medizinstudium. Der integrative Kursus "Nervensystem und Verhalten" an der LMU München.
Grunze H, Strupp M, Rönneberg T, Putz R.
Nervenarzt. 2004 Jan;75(1):67-70.
PMID: 14722665.
Levetiracetam in the treatment of acute mania: an open add-on study with an on-off-on design.
Grunze H, Langosch J, Born C, Schaub G, Walden J.
J Clin Psychiatry. 2003 Jul;64(7):781-4.
PMID: 12934978.
Lithium in the acute treatment of bipolar disorders-a stocktaking.
Grunze H.
Eur Arch Psychiatry Clin Neurosci. 2003 Jun;253(3):115-9.
PMID: 12904974.
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania.
Grunze H, Kasper S, Goodwin G, Bowden C, Baldwin D, Licht RW, Vieta E, Möller HJ; WFSBP Task Force on Treatment Guidelines for Bipolar Disorders.
World J Biol Psychiatry. 2003 Jan;4(1):5-13.
PMID: 12582971.
The use of atypical antipsychotics in Bipolar Spectrum disorders.
Grunze H, Möller HJ.
Indian J Psychiatry. 2003 Jan;45(1):10-5.
PMID: 21206806
The evolution of antiepileptic drugs for mood stabilization and their main mechanisms of action. Amann B, Grunze H.
Expert Rev Neurother. 2003 Jan;3(1):107-18.
PMID: 19810853
Acute antimanic efficacy and safety of oxcarbazepine in an open trial with an on-off-on design. Hummel B, Walden J, Stampfer R, Dittmann S, Amann B, Sterr A, Schaefer M, Frye MA, Grunze H. Bipolar Disord. 2002 Dec;4(6):412-7.
PMID: 12519102.
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression.
Grunze H, Kasper S, Goodwin G, Bowden C, Baldwin D, Licht R, Vieta E, Möller HJ; World Federation of Societies of Biological Psychiatry Task Force on Treatment Guidelines for Bipolar Disorders
World J Biol Psychiatry. 2002 Jul;3(3):115-24.
PMID: 12478876.
Psychopharmakotherapie bipolarer affektiver Erkrankungen.
Grunze H, Walden J, Dittmann S, Berger M, Bergmann A, Bräunig P, Dose M, Emrich HM, Gastpar M, Greil W, Krüger S, Möller HJ, Uebelhack R.
Nervenarzt. 2002 Jan;73(1):4-17; quiz 18-9.
PMID: 11975062.
Klinische Relevanz und Behandlungsmöglichkeiten von Rapid Cycling bei Patienten mit bipolarer affektiver Störung.
Amann B, Stampfer R, Schmidt F, Mikhaiel P, Hummel B, Sterr A, Schäfer M, Grunze H.
Fortschr Neurol Psychiatr. 2001 Dec;69(12):569-80.
PMID: 11753745.
Central pontine myelinolysis in a patient with anorexia nervosa.
Amann B, Schäfer M, Sterr A, Arnold S, Grunze H.
Int J Eat Disord. 2001 Dec;30(4):462-6.
PMID: 11746309.
Kava pyrones exert effects on neuronal transmission and transmembraneous cation currents similar to established mood stabilizers--a review.
Grunze H, Langosch J, Schirrmacher K, Bingmann D, Von Wegerer J, Walden J.
Prog Neuropsychopharmacol Biol Psychiatry. 2001 Nov;25(8):1555-70.
PMID: 11642654.
Antimanic efficacy of topiramate in 11 patients in an open trial with an on-off-on design.
Grunze HC, Normann C, Langosch J, Schaefer M, Amann B, Sterr A, Schloesser S, Kleindienst N, Walden J.
J Clin Psychiatry. 2001 Jun;62(6):464-8.
PMID: 11465524
An open longitudinal study of patients with bipolar rapid cycling treated with lithium or lamotrigine for mood stabilization.
Walden J, Schaerer L, Schloesser S, Grunze H.
Bipolar Disord. 2000 Dec;2(4):336-9.
PMID: 11252647.
Wirksamkeit, Verträglichkeit und Praktikabilität von Valproat-Miniretardtabletten bei bipolaren affektiven Störungen.
Grunze H, Amann B, Schäfer M, Sterr A, Schaerer L, Wild E, Walden J.
Fortschr Neurol Psychiatr. 2000 Nov;68(11):496-502.
PMID: 11144934.
New perspectives in the acute treatment of bipolar depression.
Grunze H, Schlösser S, Walden J.
World J Biol Psychiatry. 2000 Jul;1(3):129-36.
PMID: 12607221.
Psychopathological changes preceding motor symptoms in Huntington's disease: a report on four cases.
Amann B, Sterr A, Thoma H, Messer T, Kapfhammer HP, Grunze H.
World J Biol Psychiatry. 2000 Jan;1(1):55-8.
PMID: 12607233.
Treatment of tardive akathisia with clonidine: a case report.
Amann B, Erfurth A, Grunze H.
Int J Neuropsychopharmacol. 1999 Jun;2(2):151-153.
PMID: 11281983.
Neurotoxicity of NMDA antagonists: a glutamatergic theory of schizophrenia based on selective
impairment of local inhibitory feedback circuits.
Grunze H, Bender A, Wendhof S, Schäfer M, Rujescu D.
Dialogues Clin Neurosci. 2000 Sep;2(3):287-98.
PMID: 22033472
Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants?
Möller HJ, Grunze H
Eur Arch Psychiatry Clin Neurosci. 2000;250(2):57-68.
PMID: 10853919.
Bupropion-induced isolated impairment of sensory trigeminal nerve function.
Amann B, Hummel B, Rall-Autenrieth H, Walden J, Grunze H.
Int Clin Psychopharmacol. 2000 Mar;15(2):115-6.
PMID: 10759343.
Psychopathological and auditory evoked potential correlates of ketamine psychosis--a single case report.
Grunze H, Gallinat J, Haag C, Hegerl U.
Schizophr Res. 2000 Jan 21;41(2):386-8.
PMID: 10708350.
Tiagabine appears not to be efficacious in the treatment of acute mania.
Grunze H, Erfurth A, Marcuse A, Amann B, Normann C, Walden J.
J Clin Psychiatry. 1999 Nov;60(11):759-62.
PMID: 10584764.
Trimipramine fails to exert antimanic efficacy: a case of the discrepancy between in vitro rationale and clinical efficacy.
Grunze H, Erfurth A, Walden J.
Clin Neuropharmacol. 1999 Sep-Oct;22(5):298-300.
PMID: 10516883.
Intravenous valproate loading in acutely manic and depressed bipolar I patients.
Grunze H, Erfurth A, Amann B, Giupponi G, Kammerer C, Walden J.
J Clin Psychopharmacol. 1999 Aug;19(4):303-9.
PMID: 10440456.
Elektrokonvulsionstherapie in der Behandlung der schweren Manie. Kasuistik und Wissensstand. Grunze H, Erfurth A, Schäfer M, Amann B, Meyendorf R.
Nervenarzt. 1999 Jul;70(7):662-7.
PMID: 10434267.
Gabapentin in der Behandlung der akuten Manie.
Grunze H, Erfurth A, Amann B, Normann C, Walden J.
Fortschr Neurol Psychiatr. 1999 Jun;67(6):256-60.
PMID: 10399045.
Anticonvulsant drugs in bipolar disorder.
Grunze H, Schlösser S, Amann B, Walden J.
Dialogues Clin Neurosci. 1999 Jun;1(1):24-40.
PMID: 22033602;
Wirksamkeitsprädiktoren für Phasenprophylaktika (Stimmungsstabilisierer) bei bipolaren affektiven Störungen.
Walden J, Normann C, Langosch J, Grunze H.
Fortschr Neurol Psychiatr. 1999 Feb;67(2):75-80.
PMID: 10093780.
Schwere therapieresistente Depression als Erstmanifestation eines Morbus Parkinson.
Amann B, Erfurth A, Back T, Grunze H.
Psychiatr Prax. 1999 Jan;26(1):45-7.
PMID: 10087578.
New perspectives in the treatment of acute mania: a single case report.
Erfurth A, Grunze H.
Prog Neuropsychopharmacol Biol Psychiatry. 1998 Aug;22(6):1053-9.
PMID: 9789888.
Lamotrigine in the treatment of schizoaffective disorder.
Erfurth A, Walden J, Grunze H.
Neuropsychobiology. 1998 Oct;38(3):204-5.
PMID: 9778612.
Female genital disorder as adverse symptom of lamotrigine treatment. A serotoninergic effect? Erfurth A, Amann B, Grunze H.
Neuropsychobiology. 1998 Oct;38(3):200-1.
PMID: 9778610.
Renal impairment as a possible side effect of gabapentin. A single case report.
Grunze H, Dittert S, Bungert M, Erfurth A.
Neuropsychobiology. 1998 Oct;38(3):198-9.
PMID: 9778609.
Differential treatment of bipolar disorder with old and new antiepileptic drugs.
Walden J, Normann C, Langosch J, Berger M, Grunze H.
Neuropsychobiology.1998 Oct;38(3):181-4.
PMID: 9778606.
Modulation of calcium and potassium currents by lamotrigine.
Grunze H, von Wegerer J, Greene RW, Walden J.
Neuropsychobiology. 1998 Oct;38(3):131-8.
PMID: 9778600.
Lamotrigine may limit pathological excitation in the hippocampus by modulating a transient potassium outward current
Grunze H, Greene RW, Möller HJ, Meyer T, Walden J.
Brain Res. 1998 Apr 27;791(1-2):330-4.
PMID: 9593976.
Reduction of the frequency of occurrence of low magnesium induced field potentials in the hippocampus slice preparation of guinea pigs: a good screening tool for calcium antagonistic effects of anticonvulsantand antipsychotic drugs.
Grunze H, Walden J.
Magnes Res. 1997 Jun;10(2):119-26.
PMID: 9368232.
Effects of kawain and dihydromethysticin on field potential changes in the hippocampus.
Walden J, von Wegerer J, Winter U, Berger M, Grunze H
Prog.Neuropsychopharmacol Biol Psychiatry. 1997 May;21(4):697-706.
PMID: 9194150.
Combined treatment with lithium and nimodipine in a bipolar I manic syndrome
Grunze H, Walden J, Wolf R, Berger M.
Prog Neuropsychopharmacol Biol Psychiatry. 1996 Apr;20(3):419-26.
PMID: 8771598.
NMDA-dependent modulation of CA1 local circuit inhibition.
Grunze HC, Rainnie DG, Hasselmo ME, Barkai E, Hearn EF, McCarley RW, Greene RW.
J Neurosci. 1996 Mar 15;16(6):2034-43.
PMID: 8604048.
A calcium antagonist for the treatment of depressive episodes: single case reports.
Walden J, Fritze J, Van Calker D, Berger M, Grunze H.
J Psychiatr Res. 1995 Jan-Feb;29(1):71-6.
PMID: 7629758.
Generalisierte epileptische Anfälle unter Behandlung mit Clozapin. Häufigkeit, Typen, Prognose und Empfehlungen hinsichtlich therapeutischer Strategien.
Gouzoulis-Mayfrank E, Kasper J, Grunze H.
Nervenarzt. 1994 Nov;65(11):792-4.
PMID: 7816157.
Clinical correlates of sustained response to individual drugs used in naturalistic treatment of patients with bipolar disorder.
Post RM, Leverich GS, Kupka R, Keck PE Jr, McElroy SL, Altshuler LL, Frye MA, Rowe M, Grunze H, Suppes T, Nolen WA.
Compr Psychiatry. 2016 Apr;66:146-156.
PMID: 26995248.
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology.
Goodwin GM, Haddad PM, Ferrier IN, Aronson JK, Barnes T, Cipriani A, Coghill DR, Fazel S, Geddes JR, Grunze H, Holmes EA, Howes O, Hudson S, Hunt N, Jones I, Macmillan IC, McAllister-Williams H, Miklowitz DR, Morriss R, Munafo M, Paton C, Saharkian BJ, Saunders K, Sinclair J, Taylor D, Vieta E, Young AH.
J Psychopharmacol. 2016 Mar 15. pii: 0269881116636545. [Epub ahead of print]
PMID: 26979387.
World Federation of Societies of Biological Psychiatry (WFSBP) Consensus. Assessment and management of agitation in psychiatry: Expert Consensus
Garriga M, Pacchiarotti I, Kasper S, Zeller S, Allen MH,Vazquez G, Baldacara L, San L, McAllister-Williams RH, Fountoulakis KN, Courtet P, Naber D, Chan EW, Fagiolini A, Möller HJ, Grunze H, Llorca PM, Jaffe RL, Yatham LN, Mazzei DH, Passamar M, Messer T, Bernardo M, Vieta E
World Journal of Biological Psychiatry, 2016, Volume 17: 86-128
PMID: 26912127
Mixed depression in bipolar disorder: prevalence rate and clinical correlates during naturalistic follow-up in the Stanley Bipolar Network
Miller S, Mintz,J, Hellermann G, McElroy S, Nolen W, Kupka R, Leverich G, Grunze H, Altshuler L, Post R.
American Journal of Psychiatry, 2016, in press
More illness in offspring of bipolar patients from the U.S. compared to Europe.
Post RM, Altshuler LL, Kupka R, McElroy SL, Frye MA, Rowe M, Grunze H, Suppes T, Keck PE, Leverich GS, Nolen WA.
J Affect Disord. 2016 Feb;191:180-186.
PMID: 26655863.
Safety and tolerability of anticonvulsant medication in bipolar disorder.
Pichler E, Hattwich G, Grunze H, Mühlbacher M:
Expert Opin Drug Saf. 2015 Nov;14(11):1703-24.
PMID: 26359219
Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trial
McAllister-Williams RH, Anderson IM, Finkelmeyer A, Gallagher P, Grunze HC, Haddad PM, Hughes T, Lloyd AJ, Mamasoula C, McColl E, Pearce S, Siddiqi N, Sinha BN, Steen N, Wainwright J, Winter FH, Ferrier IN, Watson S; ADD Study Team
Lancet Psychiatry. 2016 Feb;3(2):117-27
PubMed PMID: 26727041.
Multigenerational Positive Family History of Psychiatric Disorders is Associated with a Poor Prognosis in Bipolar Disorder.
Post RM, Leverich GS, Kupka R, Keck P, McElroy SL, Altshuler LL, Frye MA, Rowe M, Grunze H, Suppes T, Nolen WA
The Journal of Neuropsychiatry and Clinical Neurosciences, 2015, Fall;27(4):304-10.
PubMed PMID: 26258489
Relationship of clinical course of illness variables to medical comorbidities in 900 adult outpatients with bipolar disorder.
Post RM, Altshuler L, Leverich GS, Frye MA, Suppes T, McElroy S, Keck P, Nolen WA, Kupka R, Grunze H, Rowe M.
Compr Psychiatry. 2015 Jan;56:21-8.
PMID: 25284280.
A bipolar II cohort (ABC): The association of functional disability with gender and rapid cycling.
Scott J, Grunze H, Meyer TD, Nendick J, Watkins H, Ferrier N.
J Affect Disord. 2015 Oct 1;185:204-8.
PMID: 26209962.
Verbal, like Physical and Sexual, Abuse in Childhood Is Associated with an Earlier Onset and More Difficult Course of Bipolar Disorder
Post RM, Altshuler L, Kupka R, McElroy S, Frye MA, Rowe M, Leverich GS, Grunze H, Suppes T, Keck P, Nolen WA..
Bipolar Disord. 2015 May;17(3):323-30
PMID: 25307301
Methodological approaches and magnitude of the clinical unmet need associated with amotivation in mood disorders.
Calabrese R, Fava M, Garibaldi G, Grunze H, Krystal A, Laughren T, Macfadden W, Marin R, Nierenberg A, Tohen M.
J. Affect. Dis. 2014; 168:439-51
PMID: 25113957
Increases in multiple psychiatric disorders n parents and grandparents of patients with bipolar disorder from the USA compared with The Netherlands and Germany.
Post RM, Leverich GS, Kupka R, Keck PE Jr, McElroy SL, Altshuler LL, Frye MA, Rowe M, Grunze H, Suppes T, Nolen WA. Psychiatr Genet. 2015 Oct;25(5):194-200.
PMID: 26146875.
Randomised controlled trial of Antiglucocorticoid augmentation (metyrapone) of antiDepressants in Depression (ADD Study).
Ferrier IN, Anderson IM, Barnes J, Gallagher P, Grunze HCR, Haddad PM, House
AO, Hughes T, Lloyd AJ, Mamasoula C, McColl E, Pearce S, Siddiqi N, Sinha B,
Speed C, Steen N, Wainwright J, Watson S, Winter FH, McAllister-Williams RH.
NIHR Journals Library; 2015 Jun.
PMID: 26086063.
Saving time and money: a validation of the self ratings on the prospective NIMH life-chart method (NIMH-LCM).
Born C, Amann BL, Grunze H, Post RM, Schärer L.
BMC Psychiatry 2014, 14:130 (7 May 2014)
PM D 24886463
More pernicious course of bipolar disorder in the United States than in many European countries: implications for policy and treatment.
Post RM, Altshuler L, Kupka R, McElroy S, Frye MA, Rowe M, Leverich GS, Grunze H, Suppes T, Keck PE Jr, Nolen WA.
J Affect Disord. 2014 May;160:27-33. Epub 2014 Feb 10.
PMID: 24709019.
When to start aripiprazole therapy in patients with bipolar mania.
Sayyaparaju KK, Grunze H, Fountoulakis KN.
Neuropsychiatr Dis Treat. 2014 Mar 13;10:459-470. eCollection 2014.
PMID: 24648740
More medical comorbidities in patients with bipolar disorder from the United States than from the Netherlands and Germany.
Post RM, Altshuler LL, Leverich GS, Frye MA, Suppes T, McElroy SL, Keck PE Jr, Nolen WA, Kupka RW, Grunze H, Rowe M.
J Nerv Ment Dis. 2014 Apr;202(4):265-70.
PMID: 24647213.
Phenomenology of manic episodes according to the presence or absence of depressive features as defined in DSM-5: Results from the IMPACT self-reported online survey.
Vieta E, Grunze H, Azorin JM, Fagiolini A.
J Affect Disord. 2014 Mar;156:206-13. Epub 2014 Jan 1.
PMID: 24439831.
Increased parental history of bipolar disorder in the United States: association with early age of onset.
Post RM, Leverich GS, Kupka R, Keck P Jr, McElroy S, Altshuler L, Frye MA, Luckenbaugh DA, Rowe M, Grunze H, Suppes T, Nolen WA.
Acta Psychiatr Scand. 2014 May;129(5):375-82. Epub 2013 Oct 19.
PMID: 24138298.
Family environment of bipolar families: a UK study.
Barron E, Sharma A, Le Couteur J, Rushton S, Close A, Kelly T, Grunze H, Ferrier IN, Le Couteur A.
J Affect Disord. 2014 Jan;152-154:522-5. Epub 2013 Sep 16.
PMID: 24091305.
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders.
Pacchiarotti I, Bond DJ, Baldessarini RJ, Nolen WA, Grunze H, Licht RW, Post RM, Berk M, Goodwin GM, Sachs GS, Tondo L, Findling RL, Youngstrom EA, Tohen M, Undurraga J, González-Pinto A, Goldberg JF, Yildiz A, Altshuler LL, Calabrese JR, Mitchell PB, Thase ME, Koukopoulos A, Colom F, Frye MA, Malhi GS, Fountoulakis KN, Vázquez G, Perlis RH, Ketter TA, Cassidy F, Akiskal H, Azorin JM, Valentí M, Mazzei DH, Lafer B, Kato T, Mazzarini L, Martínez-Aran A, Parker G, Souery D, Ozerdem A, McElroy SL, Girardi P, Bauer M, Yatham LN, Zarate CA, Nierenberg AA, Birmaher B, Kanba S, El-Mallakh RS, Serretti A, Rihmer Z, Young AH, Kotzalidis GD, MacQueen GM, Bowden CL, Ghaemi SN, Lopez-Jaramillo C, Rybakowski J, Ha K, Perugi G, Kasper S, Amsterdam JD, Hirschfeld RM, Kapczinski F, Vieta E.
Am J Psychiatry. 2013 Nov 1;170(11):1249-62.
PMID: 24030475.
More stressors prior to and during the course of bipolar illness in patients from the United States compared with the Netherlands and Germany.
Post RM, Altshuler L, Leverich G, Nolen W, Kupka R, Grunze H, Frye M, Suppes T, McElroy S, Keck P, Rowe M.
Psychiatry Res. 2013 Dec 30;210(3):880-6. Epub 2013 Sep 8.
PMID: 24021999.
Study protocol for the randomised controlled trial: Antiglucocorticoid augmentation of
anti-Depressants in Depression (The ADD Study).
McAllister-Williams RH, Smith E, Anderson IM, Barnes J, Gallagher P, Grunze HC, Haddad PM, House AO, Hughes T, Lloyd AJ, McColl EM, Pearce SH, Siddiqi N, Sinha B, Speed C, Steen IN, Wainright J, Watson S, Winter FH, Ferrier IN.
BMC Psychiatry. 2013 Aug 3;13(1):205. [Epub ahead of print]
PMID: 23914988
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders.
Bauer M, Pfennig A, Severus E, Whybrow PC, Angst J, Möller HJ; World Federation of Societies of Biological Psychiatry. Task Force on Unipolar Depressive Disorders.
World J Biol Psychiatry. 2013 Jul;14(5):334-85. Epub 2013 Jul 3.
PMID: 23879318.
Role of childhood adversity in the development of medical co-morbidities associated with bipolar disorder.
Post RM, Altshuler LL, Leverich GS, Frye MA, Suppes T, McElroy SL, Keck PE Jr, Nolen WA, Kupka RW, Grunze H, Rowe M.
J Affect Disord. 2013 May;147(1-3):288-94. Epub 2013 Jan 18.
PMID: 23337654
Treatment patterns in inpatients with bipolar disorder at a psychiatric university hospital over a 9-year period: focus on mood stabilizers.
Walpoth-Niederwanger M, Kemmler G, Grunze H, Weiss U, Hörtnagl C, Strauss R, Blasko I, Hausmann A.
Int Clin Psychopharmacol. 2012 Sep;27(5):256-66.
PMID: 22842799.
Ziprasidone—not haloperidol--induces more de-novo neurogenesis of adult neural stem cells derived from murine hippocampus.
Benninghoff J, Grunze H, Schindler C, Genius J, Schloesser RJ, van der Ven A, Dehning S, Wiltfang J, Möller HJ, Rujescu D.
Pharmacopsychiatry. 2013 Jan;46(1):10-5.Epub 2012 May 16.
PMID: 22592505.
Relationship of prior antidepressant exposure to long-term prospective outcome in bipolar I disorder outpatients.
Post RM, Leverich GS, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE Jr, Nolen WA, Rowe M, Kupka RW, Grunze H, Goodwin FK.
J Clin Psychiatry. 2012 Jul;73(7):924-30. Epub 2012 Mar 20.
PMID: 22480597.
The potential role of Marginal Structural Models (MSMs) in testing the effectiveness of antidepressants in the treatment of patients with major depression in everyday clinical practice.
Severus E, Lipkovich I, Seemüller F, Obermeier M, Grunze H, Bernhard B, Dittmann S, Riedel M, Möller HJ.
World J Biol Psychiatry. 2013 Jul;14(5):386-95. Epub 2011 Nov 18.
PMID: 22098147.
Aripiprazole in patients with bipolar mania and beyond: an update of practical
guidance.
Goodwin GM, Abbar M, Schlaepfer TE, Grunze H, Licht RW, Bellivier F,
Fountoulakis KN, Altamura AC, Pitchot W, Ågren H, Holsboer-Trachsler E, Vieta E.
Curr Med Res Opin. 2011 Dec;27(12):2285-99. Epub 2011 Oct 21.
PMID: 22014287.
Impaired functioning in euthymic patients with bipolar disorder--HSV-1 as a predictor.
Gerber SI, Krienke UJ, Biedermann NC, Grunze H, Yolken RH, Dittmann S, Langosch JM.
Prog Neuropsychopharmacol Biol Psychiatry. 2012 Jan 10;36(1):110-6. Epub 2011 Sep 14.
PMID: 21945379.
Reliabilitat und Ubereinstimmungsvaliditat der deutschen Version der Young Mania Rating Scale (YMRS-D).
Mühlbacher M, Egger C, Kaplan P, Simhandl C, Grunze H, Geretsegger C, Whitworth A, Stuppäck C.
Neuropsychiatr.2011;25(1):16-25.
PMID: 21486540.
Differential clinical characteristics, medication usage, and treatment response of bipolar disorder in
the US versus The Netherlands and Germany
Post RM, Leverich GS, Altshuler LL, Frye MA, Suppes T, Keck PE, McElroy SL, Nolen WA, Kupka R, Grunze H, Walden J, Rowe M.
Int Clin Psychopharmacol. 2011 Mar;26(2):96-106.
PMID: 21178634.
2-Year course of bipolar disorder type I patients in outpatient care: factors associated with remission and functional recovery.
Haro JM, Reed C, Gonzalez-Pinto A, Novick D, Bertsch J, Vieta E; EMBLEM Advisory Board.
Eur Neuropsychopharmacol. 2011 Apr;21(4):287-93. Epub 2010 Oct 16.
PMID: 20956071.
Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder.
Post RM, Altshuler LL, Frye MA, Suppes T, Keck PE Jr, McElroy SL, Leverich GS, Luckenbaugh DA, Rowe M, Pizzarello S, Kupka RW, Grunze H, Nolen WA.
J Clin Psychiatry. 2010 Sep;71(9):1176-86
PMID: 20923622.
Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood.
Post RM, Leverich GS, Kupka RW, Keck PE Jr, McElroy SL, Altshuler LL, Frye MA, Luckenbaugh DA, Rowe M, Grunze H, Suppes T, Nolen WA.
J Clin Psychiatry. 2010 Jul;71(7):864-72.
PMID: 20667291.
Work impairment in bipolar disorder patients--results from a two-year observational study (EMBLEM).
Reed C, Goetz I, Vieta E, Bassi M, Haro JM; EMBLEM Advisory Board.
Eur Psychiatry. 2010 Oct;25(6):338-44.
PMID: 20435449.
Gender and depressive symptoms in 711 patients with bipolar disorder evaluated prospectively in the Stanley Foundation bipolar treatment outcome network.
Altshuler LL, Kupka RW, Hellemann G, Frye MA, Sugar CA, McElroy SL, Nolen WA, Grunze H, Leverich GS, Keck PE, Zermeno M, Post RM, Suppes T.
Am J Psychiatry. 2010 Jun;167(6):708-15. Epub 2010 Mar 15.
PMID: 20231325.
Serotonin depletion hampers survival and proliferation in neurospheres derived from adult neural stem cells.
Benninghoff J, Gritti A, Rizzi M, Lamorte G, Schloesser RJ, Schmitt A, Robel S, Genius J, Moessner R, Riederer P, Manji HK, Grunze H, Rujescu D, Moeller HJ, Lesch KP, Vescovi AL
Neuropsychopharmacology. 2010 Mar;35(4):893-903. Epub 2009 Dec 9.
PMID: 20010549.
The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders.
Tohen M, Frank E, Bowden CL, Colom F, Ghaemi SN, Yatham LN, Malhi GS, Calabrese JR, Nolen WA, Vieta E, Kapczinski F, Goodwin GM, Suppes T, Sachs GS, Chengappa KR, Grunze H, Mitchell PB, Kanba S, Berk M.
Bipolar Disord. 2009 Aug;11(5):453-73.
PMID: 19624385.
Translation of randomised controlled trial findings into clinical practice: comparison of olanzapine and valproate in the EMBLEM study.
Novick D, Gonzalez-Pinto A, Haro JM, Bertsch J, Reed C, Perrin E, Tohen M; EMBLEM Advisory Board.
Pharmacopsychiatry. 2009 Jul;42(4):145-52. Epub 2009 Jul 7.
PMID: 19585393.
Anticonvulsants in the treatment of aggression in the demented elderly: an update.
Amann B, Pantel J, Grunze H, Vieta E, Colom F, Gonzalez-Pinto A, Naber D, Hampel H.
Clin Pract Epidemiol Ment Health. 2009 Jun 16;5:14.
PMID: 19531220.
Preliminary results of a fine-grain analysis of mood swings and treatment modalities of bipolar I and II patients using the daily prospective life-chart-methodology.
Born C, Seitz NN, Grunze H, Vieta E, Dittmann S, Seemüller F, Amann B.
Acta Psychiatr Scand. 2009 Dec;120(6):474-80. Epub 2009 May 21.
PMID: 19485960.
Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study.
Altshuler LL, Post RM, Hellemann G, Leverich GS, Nolen WA, Frye MA, Keck PE Jr, Kupka RW, Grunze H, McElroy SL, Sugar CA, Suppes T.
J Clin Psychiatry. 2009 Apr;70(4):450-7. Epub 2009 Apr 7.
PMID: 19358785.
Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
Vieta E, Angst J, Reed C, Bertsch J, Haro JM; EMBLEM advisory board.
J Affect Disord. 2009 Nov;118(1-3):118-23. Epub 2009 Mar 9.
PMID: 19269690.
Spezifische Behandlungsaspekte bipolar erkrankter Frauen.
Sasse J, Pilhatsch M, Forsthoff A, Grunze H, Neutze J, Pfennig A, Schmitz B, Schwenkhagen A, Bauer M.
Nervenarzt. 2009 Mar;80(3):263-72.
PMID: 19229511.
Does cannabis use affect treatment outcome in bipolar disorder? A longitudinal analysis.
van Rossum I, Boomsma M, Tenback D, Reed C, van Os J; EMBLEM Advisory Board
J Nerv Ment Dis. 2009 Jan;197(1):35-40.
PMID: 19155808.
Mania in the Nordic countries: patients and treatment in the acute phase of the EMBLEM study.
Larsen JK, Porsdal V, Aarre TF, Koponen HJ, Aarnio J, Kleivenes OK; Emblem Advisory Board.
Nord J Psychiatry. 2009;63(4):285-91.
PMID: 19140076.
Bipolar disorder in the elderly; different effects of age and of age of onset.
Oostervink F, Boomsma MM, Nolen WA; EMBLEM Advisory Board.
J Affect Disord.2009 Aug;116(3):176-83. Epub 2008 Dec 14.
PMID: 19087895.
Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression.
Frye MA, Helleman G, McElroy SL, Altshuler LL, Black DO, Keck PE Jr, Nolen WA, Kupka R, Leverich GS, Grunze H, Mintz J, Post RM, Suppes T.
Am J Psychiatry. 2009 Feb;166(2):164-72. Epub 2008 Nov 17.
PMID: 19015231.
A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode.
Bowden C, Göğüş A, Grunze H, Häggström L, Rybakowski J, Vieta E.
Int Clin Psychopharmacol. 2008 Sep;23(5):254-62.
PMID: 18703934.
Geschwindigkeit des Depressionsbeginns: Ein Unterscheidungsmerkmal hinsichtlich uni- versus bipolarer affektiver Störungen.
Hegerl U, Bottner AC, Mergl R, Holtschmidt-Täschner B, Seemüller F, Scheunemann W, Schütze M, Grunze H, Henkel V, Angst J, Born C.
Neuropsychiatr. 2008;22(2):92-9.
PMID: 18606111
Stability and treatment outcome of distinct classes of mania.
van Rossum I, Haro JM, Tenback D, Boomsma M, Goetz I, Vieta E, van Os J; EMBLEM Advisory Board. Eur Psychiatry. 2008 Aug;23(5):360-7. Epub 2008 Apr 23.
PMID: 18434101.
The impact of homocysteine levels on cognition in euthymic bipolar patients: a cross-sectional study.
Dittmann S, Seemüller F, Grunze HC, Schwarz MJ, Zach J, Fast K, Born C, Dargel S, Engel RR, Bernhard B, Möller HJ, Riedel M, Severus WE.
J Clin Psychiatry. 2008 Jun;69(6):899-906.
PMID: 18399726.
Onset of depressive episodes is faster in patients with bipolar versus unipolar depressive disorder: evidence from a retrospective comparative study.
Hegerl U, Bottner AC, Holtschmidt-Täschner B, Born C, Seemüller F, Scheunemann W, Schütze M, Grunze H, Henkel V, Mergl R, Angst J.
J Clin Psychiatry. 2008 Jul;69(7):1075-80.
PMID: 18384245.
Are bipolar mood symptoms affected by the phase of the menstrual cycle?
Shivakumar G, Bernstein IH, Suppes T; Stanley Foundation Bipolar Network, Keck PE, McElroy SL, Altshuler LL, Frye MA, Nolen WA, Kupka RW, Grunze H, Leverich GS, Mintz J, Post RM.
J Womens Health (Larchmt). 2008 Apr;17(3):473-8.
PMID: 18328012.
Incidence of childhood-onset bipolar illness in the USA and Europe.
Post RM, Luckenbaugh DA, Leverich GS, Altshuler LL, Frye MA, Suppes T, Keck
PE, McElroy SL, Nolen WA, Kupka R, Grunze H, Walden J.
Br J Psychiatry. 2008 Feb;192(2):150-1
PMID: 18245035.
Treatment of bipolar depression: an update.
Fountoulakis KN, Grunze H, Panagiotidis P, Kaprinis G.
J Affect Disord. 2008 Jul;109(1-2):21-34. Epub 2007 Nov 26.
PMID: 18037498.
Risperidone monotherapy in manic inpatients: an open label, multicentre trial.
Forsthoff A, Grunze H, Seemüller F, Stampfer R, Dittmann S, Amann B, Schmidt F, Schäfer M, Hermle L, Walden J, Schreiner A.
World J Biol Psychiatry. 2007;8(4):256-61.
PMID: 17853251.
Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. Kupka RW, Altshuler LL, Nolen WA, Suppes T, Luckenbaugh DA, Leverich GS, Frye MA, Keck PE Jr, McElroy SL, Grunze H, Post RM.
Bipolar Disord. 2007 Aug;9(5):531-5.
PMID: 17680925.
A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression.
Frye MA, Grunze H, Suppes T, McElroy SL, Keck PE Jr, Walden J, Leverich GS, Altshuler LL, Nakelsky S, Hwang S, Mintz J, Post RM.
Am J Psychiatry. 2007 Aug;164(8):1242-9.
PMID: 17671288.
Alterations of hippocampal and prefrontal GABAergic interneurons in an animal model of psychosis
induced by NMDA receptor antagonism.
Braun I, Genius J, Grunze H, Bender A, Möller HJ, Rujescu D.
Schizophr Res. 2007 Dec;97(1-3):254-63. Epub 2007 Jun 29.
PMID: 17601703.
Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study.
Vieta E, Panicali F, Goetz I, Reed C, Comes M, Tohen M; EMBLEM Advisory Board.
J Affect Disord. 2008 Feb;106(1-2):63-72. Epub 2007 Jun 20.
PMID: 17582508.
Antiepileptic drugs and mood stability.
Amann B, Grunze H, Vieta E, Trimble M.
Clin EEG Neurosci. 2007 Apr;38(2):116-23.
PMID:17515177.
The poor prognosis of childhood-onset bipolar disorder.
Leverich GS, Post RM, Keck PE Jr, Altshuler LL, Frye MA, Kupka RW, Nolen WA, Suppes T, McElroy SL, Grunze H, Denicoff K, Moravec MK, Luckenbaugh D.
J Pediatr. 2007 May;150(5):485-90.
PMID: 17452221.
Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study.
Nolen WA, Kupka RW, Hellemann G, Frye MA, Altshuler LL, Leverich GS, Suppes T, Keck PE Jr, McElroy S, Grunze H, Mintz J, Post RM.
Acta Psychiatr Scand. 2007 May;115(5):360-5.
PMID: 17430413.
Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results.
Dittmann S, Seemüller F, Schwarz MJ, Kleindienst N, Stampfer R, Zach J, Born C, Bernhard B, Fast K, Grunze H, Engel RR, Severus E.
Bipolar Disord. 2007 Feb-Mar;9(1-2):63-70.
PMID: 17391351.
Developing core sets for persons with bipolar disorder based on the International Classification of Functioning, Disability and Health.
Vieta E, Cieza A, Stucki G, Chatterji S, Nieto M, Sánchez-Moreno J, Jaeger J, Grunze H, Ayuso-Mateos JL.
Bipolar Disord. 2007 Feb-Mar;9(1-2):16-24.
PMID: 17391346.
Alcoholism and anxiety in bipolar illness: differential lifetime anxiety comorbidity in bipolar I women with and without alcoholism.
Levander E, Frye MA, McElroy S, Suppes T, Grunze H, Nolen WA, Kupka R, Keck PE Jr, Leverich GS, Altshuler LL, Hwang S, Mintz J, Post RM.
J Affect Disord. 2007 Aug;101(1-3):211-7. Epub 2007 Jan 23.
PMID: 17254638.
Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: results of a large, multisite study.
Altshuler LL, Post RM, Black DO, Keck PE Jr, Nolen WA, Frye MA, Suppes T, Grunze H, Kupka RW, Leverich GS, McElroy SL, Walden J, Mintz J.
J Clin Psychiatry. 2006 Oct;67(10):1551-60.
PMID: 17107246.
Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. Post RM, Altshuler LL, Leverich GS, Frye MA, Nolen WA, Kupka RW, Suppes T, McElroy S, Keck PE, Denicoff KD, Grunze H, Walden J, Kitchen CM, Mintz J.
Br J Psychiatry. 2006 Aug;189:124-31. Erratum in: Br J Psychiatry.2006 Dec;189:569.
PMID: 16880481.
Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder.
Keck PE Jr, Mintz J, McElroy SL, Freeman MP, Suppes T, Frye MA, Altshuler LL, Kupka R, Nolen WA, Leverich GS, Denicoff KD, Grunze H, Duan N, Post RM.
Biol Psychiatry. 2006 Nov 1;60(9):1020-2. Epub 2006 Jun 30.
PMID: 16814257.
Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants.
Altshuler LL, Suppes T, Black DO, Nolen WA, Leverich G, Keck PE Jr, Frye MA, Kupka R, McElroy SL, Grunze H, Kitchen CM, Post R.
Am J Psychiatry. 2006 Feb;163(2):313-5.
PMID: 16449487.
Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.
Leverich GS, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE Jr, Kupka RW, Denicoff KD, Nolen WA, Grunze H, Martinez MI, Post RM.
Am J Psychiatry. 2006 Feb;163(2):232-9.
PMID: 16449476.
Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Network: a sex-specific phenomenon.
Suppes T, Mintz J, McElroy SL, Altshuler LL, Kupka RW, Frye MA, Keck PE Jr, Nolen WA, Leverich GS, Grunze H, Rush AJ, Post RM.
Arch Gen Psychiatry. 2005 Oct;62(10):1089-96.
PMID: 16203954.
Is the prophylactic antidepressant efficacy of lithium in bipolar I disorder dependent on study design and lithium level?
Severus WE, Grunze H, Kleindienst N, Frangou S, Moeller HJ.
J Clin Psychopharmacol. 2005 Oct;25(5):457-62.
PMID: 16160621.
Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? A conceptual review.
Möller HJ, Grunze H, Broich K.
Eur Arch Psychiatry Clin Neurosci. 2006 Feb;256(1):1-16. Epub 2005 Aug 4.
PMID: 16078087.
Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
Tohen M, Greil W, Calabrese JR, Sachs GS, Yatham LN, Oerlinghausen BM, Koukopoulos A, Cassano GB, Grunze H, Licht RW, Dell'Osso L, Evans AR, Risser R, Baker RW, Crane H, Dossenbach MR, Bowden CL.
Am J Psychiatry. 2005 Jul;162(7):1281-90.
PMID: 15994710.
Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients.
Kupka RW, Luckenbaugh DA, Post RM, Suppes T, Altshuler LL, Keck PE Jr, Frye MA, Denicoff KD, Grunze H, Leverich GS, McElroy SL, Walden J, Nolen WA.
Am J Psychiatry. 2005 Jul;162(7):1273-80.
PMID: 15994709.
Reproductive function and risk for PCOS in women treated for bipolar disorder.
Rasgon NL, Altshuler LL, Fairbanks L, Elman S, Bitran J, Labarca R, Saad M, Kupka R, Nolen WA, Frye MA, Suppes T, McElroy SL, Keck PE Jr, Leverich G, Grunze H, Walden J, Post R, Mintz J
Bipolar Disord. 2005 Jun;7(3):246-59.
PMID: 15898962.
Open-label adjunctive zonisamide in the treatment of bipolar disorders: a prospective trial.
McElroy SL, Suppes T, Keck PE Jr, Black D, Frye MA, Altshuler LL, Nolen WA, Kupka RW, Leverich GS, Walden J, Grunze H, Post RM.
J Clin Psychiatry. 2005 May;66(5):617-24.
PMID: 15889949.
A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder.
Bowden CL, Grunze H, Mullen J, Brecher M, Paulsson B, Jones M, Vågerö M, Svensson K.
J Clin Psychiatry. 2005 Jan;66(1):111-21.
PMID: 15669897.
Serum levels of substance P and response to antidepressant pharmacotherapy.
Lieb K, Walden J, Grunze H, Fiebich BL, Berger M, Normann C.
Pharmacopsychiatry. 2004 Sep;37(5):238-9.
PMID: 15470802.
Paroxetine in major depression: correlating plasma concentrations and clinical response.
Normann C, Hörn M, Hummel B, Grunze H, Walden J.
Pharmacopsychiatry. 2004 May;37(3):123-6.
PMID: 15138896.
Use of quetiapine in bipolar disorder: a case series with prospective evaluation.
Suppes T, McElroy SL, Keck PE, Altshuler L, Frye MA, Grunze H, Leverich GS, Nolen WA, Chisholm K, Dennehy EB, Post RM.
Int Clin Psychopharmacol. 2004 May;19(3):173-4.
PMID: 15107662.
A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.
Goodwin GM, Bowden CL, Calabrese JR, Grunze H, Kasper S, White R, Greene P, Leadbetter R.
J Clin Psychiatry. 2004 Mar;65(3):432-41.
PMID: 15096085
EEG abnormalities associated with antipsychotics: a comparison of quetiapine, olanzapine, haloperidol and healthy subjects.
Amann BL, Pogarell O, Mergl R, Juckel G, Grunze H, Mulert C, Hegerl U.
Hum Psychopharmacol. 2003 Dec;18(8):641-6.
PMID: 14696024.
A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network.
Post RM, Leverich GS, Nolen WA, Kupka RW, Altshuler LL, Frye MA, Suppes T, McElroy S, Keck P, Grunze H, Walden J.
Bipolar Disord.2003 Dec;5(6):396-406.
PMID: 14636363.
An overview of recent findings of the Stanley Foundation Bipolar Network (Part I).
Post RM, Leverich GS, Altshuler LL, Frye MA, Suppes TM, Keck PE Jr, McElroy SL, Kupka R, Nolen WA, Grunze H, Walden J.
Bipolar Disord. 2003 Oct;5(5):310-9.
PMID: 14525551.
Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up.
Altshuler L, Suppes T, Black D, Nolen WA, Keck PE Jr, Frye MA, McElroy S, Kupka R, Grunze H, Walden J, Leverich G, Denicoff K, Luckenbaugh D, Post R.
Am J Psychiatry. 2003 Jul;160(7):1252-62.
PMID: 12832239.
The clinical use of gabapentin in bipolar spectrum disorders.
Carta MG, Hardoy MC, Hardoy MJ, Grunze H, Carpiniello B.
J Affect Disord. 2003 Jun;75(1):83-91.
PMID: 12781355.
Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network.
Leverich GS, Altshuler LL, Frye MA, Suppes T, Keck PE Jr, McElroy SL, Denicoff KD, Obrocea G, Nolen WA, Kupka R, Walden J, Grunze H, Perez S, Luckenbaugh DA, Post RM.
J Clin Psychiatry. 2003 May;64(5):506-15.
PMID: 12755652.
Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder.
Frye MA, Altshuler LL, McElroy SL, Suppes T, Keck PE, Denicoff K, Nolen WA, Kupka R, Leverich GS, Pollio C, Grunze H, Walden J, Post RM.
Am J Psychiatry. 2003 May;160(5):883-9.
PMID: 12727691.
Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.
Schaefer M, Schmidt F, Folwaczny C, Lorenz R, Martin G, Schindlbeck N, Heldwein W, Soyka M, Grunze H, Koenig A, Loeschke K.
Hepatology. 2003 Feb;37(2):443-51.
PMID: 12540795.
Interferon alpha (IFNalpha) and psychiatric syndromes: a review.
Schaefer M, Engelbrecht MA, Gut O, Fiebich BL, Bauer J, Schmidt F, Grunze H, Lieb K.
Prog Neuropsychopharmacol Biol Psychiatry. 2002 May;26(4):731-46.
PMID: 12188106.
Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study.
Normann C, Hummel B, Schärer LO, Hörn M, Grunze H, Walden J.
J Clin Psychiatry. 2002 Apr;63(4):337-44.
PMID: 12000208.
Correlates of overweight and obesity in 644 patients with bipolar disorder.
McElroy SL, Frye MA, Suppes T, Dhavale D, Keck PE Jr, Leverich GS, Altshuler L, Denicoff KD, Nolen WA, Kupka R, Grunze H, Walden J, Post RM.
J Clin Psychiatry. 2002 Mar;63(3):207-13.
PMID: 11926719.
Are antidepressants less effective in the acute treatment of bipolar I compared to
unipolar depression?
Möller HJ, Bottlender R, Grunze H, Strauss A, Wittmann J.
J Affect Disord. 2001 Dec;67(1-3):141-6.
PMID: 11869761.
The use of tiagabine in affective disorders.
Carta MG, Hardoy MC, Grunze H, Carpiniello B.
Pharmacopsychiatry. 2002 Jan;35(1):33-4.
PMID: 11819159.
Interferon-alpha-assoziierte Agranulozytose wahrend Clozapin-Behandlung. Kasuistik und Wissensstand.
Schäfer M, Schmidt F, Grunze H, Laakmann G, Loeschke K.
Nervenarzt. 2001 Nov;72(11):872-5.
PMID: 11758095.
Nichtletale Wirkung hochtoxischer Amitriptylin-Spiegel nach Suizidversuch. Ein Fallbericht
Amann B, Grunze H, Hoffmann J, Schäfer M, Kuss HJ.
Nervenarzt. 2001 Jan;72(1):52-5.
PMID: 11221556.
Effects of lamotrigine on field potentials and long-term potentiation in guinea pig hippocampal slices.
Langosch JM, Zhou XY, Frick A, Grunze H, Walden J.
Epilepsia. 2000 Sep;41(9):1102-6.
PMID: 10999548.
Cognitive dysfunction in schizophrenia: unifying basic research and clinical aspects.
McCarley RW, Niznikiewicz MA, Salisbury DF, Nestor PG, O'Donnell BF, Hirayasu Y, Grunze H, Greene RW, Shenton ME.
Eur Arch Psychiatry Clin Neurosci. 1999;249 Suppl 4:69-82.
PMID: 10654112
An open label study of gabapentin in the treatment of acute mania.
Erfurth A, Kammerer C, Grunze H, Normann C, Walden J.
J Psychiatr Res. 1998 Sep-Oct;32(5):261-4.
PMID: 9789203.
Acetazolamide in the treatment of acute mania. A case report.
Brandt C, Grunze H, Normann C, Walden J.
Neuropsychobiology. 1998 Oct;38(3):202-3.
PMID: 9778611.
Induction of cytokine synthesis and fever suppresses REM sleep and improves mood in patients with major depression.
Bauer J, Hohagen F, Gimmel E, Bruns F, Lis S, Krieger S, Ambach W, Guthmann A, Grunze H, Fritsch-Montero R, et al.
Biol Psychiatry. 1995 Nov 1;38(9):611-21.
PMID: 8573663.
Influence of biperiden and bornaprine on sleep in healthy subjects.
Hohagen F, Lis S, Riemann D, Krieger S, Meyer C, Montero RF, Grunze H, Berger M.
Neuropsychopharmacology. 1994 Aug;11(1):29-32
PMID: 7945741.
Adenosine inhibition of mesopontine cholinergic neurons: implications for EEG arousal
Rainnie DG, Grunze HC, McCarley RW, Greene RW.
Science. 1994 Feb 4;263(5147):689-92. Erratum in: Science 1994 Jul 1;265(5168):16.
PMID: 8303279
Calcium-antagonistic effects of carbamazepine in epilepsies and affective psychoses.
Walden J, Grunze H, Mayer A, Düsing R, Schirrmacher K, Liu Z, Bingmann D.
Neuropsychobiology. 1993;27(3):171-5.
PMID: 8232834.
Calcium antagonistic effects of carbamazepine as a mechanism of action in neuropsychiatric disorders: studies in calcium dependent model epilepsies.
Walden J, Grunze H, Bingmann D, Liu Z, Düsing R.
Eur Neuropsychopharmacol. 1992 Dec;2(4):455-62.
PMID: 1490097.
Bedeutung von Kalziumionen und Kalziumantagonisten bei affektiven Psychosen.
Walden J, Grunze H, Olbrich H, Berger M.
Fortschr Neurol Psychiatr. 1992 Dec;60(12):471-6.
PMID: 1337539.
Myoclonic epileptic seizures during clozapine treatment: a report of three cases
Gouzoulis E, Grunze H, von Bardeleben U.
Eur Arch Psychiatry Clin Neurosci. 1991;240(6):370-2.
PMID: 1831670
Invited comment: "Bipolar disorder: not another meta-analysis".
Grunze H
The Lancet Psychiatry 2014, Oct;1(5):321-3
PMID: 26360983
Physical health of patients with bipolar disorder.
Young AH, Grunze H.
Acta Psychiatr Scand Suppl. 2013;(442):3-10.
PMID: 23581787.
Deeskalationstechniken und atypische Neuroleptika in der Behandlung der akuten Manie.
Amann BL, Wesuls R, Landin Romero R, Grunze H.
Fortschr Neurol Psychiatr. 2013 May;81 Suppl 1:S9-16. Epub 2013 May 16.
PMID: 23681717.
Herausforderungen der ambulanten Behandlung von Patienten mit bipolar-affektiven Störungen. Seemüller F, Berger M, Musil R, Severus E, Dittmann S, Born C, Schaub A, Dargel S, Grunze H.
Fortschr Neurol Psychiatr. 2013 May;81 Suppl 1:S35-9. Epub 2013 May 16.
PMID: 23681716.
Kognitiv-psychoedukative Gruppenintervention bei bipolar erkrankten Patienten: Pilotstudie mit Zwei-Jahres-Katamnese.
Schaub A, Neubauer N, Bernhard B, Born C, Möller HJ, Grunze H.
Fortschr Neurol Psychiatr. 2013 May;81 Suppl 1:S30-4. Epub 2013 May 16.
PMID:23681715.
Differenzialdiagnostik und Psychopharmakotherapie bipolarer Stoerungen.
Grunze H, Grunze A, Amann BL.
Fortschr Neurol Psychiatr. 2013 May;81 Suppl 1:S3-8. Epub 2013 May 16.
PMID: 23681714.
Bildgebende Verfahren bei bipolaren Erkrankungen
Grunze A, Meisenzahl E, Grunze H.
Fortschr Neurol Psychiatr. 2013 May;81 Suppl 1:S17-21. Epub 2013 May 16.
PMID: 23681711.
Comparative efficacy of anti-manic drugs in acute mania (Letter)
Grunze H, Fyans P. Lancet. 2012 Mar 10;379(9819):893; author reply 894.
PMID: 22405793.
The clinical side of bipolar disorders.
Grunze H.
Pharmacopsychiatry. 2011 May;44 Suppl 1:S43-8. Epub 2011 May 4.
PMID: 21544744.
Bipolar disorder--a focus on depression. (Letter)
Vieta E, Grunze H.
N Engl J Med. 2011 Apr 21;364(16):1581; author reply 1582.
PMID: 21506756.
Invited comment on Licht et al “How to manage mania not responding to a first-step 2 weeks treatment with quetiapine – a report from a prematurely discontinued randomised clinical trial”
Grunze H.
Acta Psychiatr Scand. 2009 Oct;120(4):335.Epub 2009 Aug 17.
PMID: 19689482.
Grunze HC, Höschl C, Montgomery SA, Sartorius N, Vieta E. Response to Shen J, Kobak K, Zhao Y.et al
Use of remote centralized raters via live 2-way video in a multicenter clinical trial for schizophrenia. (J Clin Psychopharmacol.2008;28:691-693).
J Clin Psychopharmacol. 2009 Aug;29(4):409.
PMID: 19593194.
Nur depressiv oder bipolar erkrankt? Fragen Sie nach Zeichen einer Hypomanie oder Manie!
Grunze H, Forsthoff A.
MMW Fortschr Med. 2008 May 19;150 Suppl 2:37-40.
PMID: 18678050
Rezidivprophylaxe bipolarer Erkrankungen.
Sterr A, Amann B, Grunze H.
Psychiatr Prax. 2006 Mar;33 Suppl 1:S47-54.
PMID: 16511731.
Leitlinien zur Therapie der akuten Manie.
Krüger S, Bräunig P, Grunze H.
Psychiatr Prax. 2006 Mar;33 Suppl 1:S2-6.
PMID: 16511724.
Reevaluating therapies for bipolar depression.
Grunze H.
J Clin Psychiatry. 2005;66 Suppl 5:17-25.
PMID: 16038598
Bipolare Störungen differenziert behandeln: Manie, Depression oder Mischzustand?
Forsthoff A, Born C, Grunze H.
MMW Fortschr Med. 2005 May 17;147 Spec No 2:32-6.
PMID: 15968870.
Antiepileptic drugs in mood-disordered patients.
Gajwani P, Forsthoff A, Muzina D, Amann B, Gao K, Elhaj O, Calabrese JR, Grunze H.
Epilepsia. 2005;46Suppl 4:38-44.
PMID: 15968808.
Neurochemical underpinnings in bipolar disorder and epilepsy.
Amann B, Grunze H.
Epilepsia. 2005;46 Suppl 4:26-30.
PMID: 15938708.
Bei jeder Depression immer auch an bipolare Erkrankungen denken. Die verkannte Manie.
Grunze H, Sasse J, Forsthoff A, Bauer M.
MMW Fortschr Med. 2004 May 24;146 Spec No 2:4-6, 8.
PMID: 15376694.
Therapie der akuten bipolaren Erkrankung. Kniffliger Balanceakt zwischen Manie und Depression Grunze H, Dittmann S.
MMW Fortschr Med. 2003 May 26;145 Suppl 2:27-30.
PMID: 14579481.
Relevance of new and newly rediscovered anticonvulsants for atypical forms of bipolar disorder.
Grunze H, Walden J.
J Affect Disord. 2002 Dec;72 Suppl 1:S15-21.
PMID: 12589899.
Nefazodone in psychotic unipolar and bipolar depression: a retrospective chart analysis and open prospective study on its efficacy and safety versus combined treatment with amitriptyline and haloperidol.
Grunze H, Marcuse A, Schärer LO, Born C, Walden J.
Neuropsychobiology. 2002;46 Suppl 1:31-5.
PMID: 12571431
Clozapine as add-on medication in the maintenance treatment of bipolar and schizoaffective
disorders. A case series.
Hummel B, Dittmann S, Forsthoff A, Matzner N, Amann B, Grunze H.
Neuropsychobiology. 2002;45 Suppl 1:37-42.
PMID: 11893876.
Clinical relevance and treatment possibilities of bipolar rapid cycling.
Grunze H, Amann B, Dittmann S, Walden J.
Neuropsychobiology. 2002;45 Suppl 1:20-6.
PMID: 11893873.
Short-term and long-term effects of N-methyl-D-aspartate receptor hypofunction (Letter)
Greene R, Bergeron R, McCarley R, Coyle JT, Grunze H.
Arch Gen Psychiatry. 2000 Dec;57(12):1180-1; author reply 1182-3.
PMID: 11115333.
Adding low-dose antidepressants to interferon alpha treatment for chronic hepatitis C improved psychiatric tolerability in a patient with schizoaffective psychosis.
Schäfer M, Schmidt F, Amann B, Schlösser S, Loeschke K, Grunze H.
Neuropsychobiology. 2000;42 Suppl 1:43-5.
PMID: 11093071.
Modulation of neural cell membrane conductance by the herbal anxiolytic and antiepileptic drug aswal.
Grunze H, Langosch J, von Loewenich C, Walden J.
Neuropsychobiology. 2000;42 Suppl 1:28-32.
PMID: 11093068.
Kommentar zu: M Adli, T.Bschor, B. Canata. S. Döpfmer, M. Bauer: Lithium in the treatment of acute depression. Fortschr Neurol Psychiat 1998; 66: 43.
Grunze H, Schlösser S, Walden J.
Fortschr Neurol Psychiatr. 1999 Aug;67(8):384-6.
PMID: 10478303.
Treatment options for acute depression in bipolar disorder.
Bauer M, Ritter P, Grunze H, Pfennig A.
Bipolar Disord. 2012 May;14 Suppl 2:37-50
PMID: 22510035.
Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence.
Sartorius N, Baghai TC, Baldwin DS, Barrett B, Brand U, Fleischhacker W, Goodwin G, Grunze H, Knapp M, Leonard BE, Lieberman J, Nakane Y, Pinder RM, Schatzberg AF, Svestka J, Baumann P, Ghalib K, Markowitz JC, Padberg F, Fink M, Furukawa T, Fountoulakis KN, Jensen P, Kanba S, Riecher-Rössler A.
Int J Neuropsychopharmacol. 2007 Dec;10 Suppl 1:S1-207.
PMID: 18096106.
Tourette's symptoms provoked by lamotrigine in a bipolar patient. (Letter)
Seemüller F, Dehning S, Grunze H, Müller N.
Am J Psychiatry. 2006 Jan;163(1):159.
PMID: 16390908.
Atypical antipsychotics in bipolar depression: potential mechanisms of action.
Yatham LN, Goldstein JM, Vieta E, Bowden CL, Grunze H, Post RM, Suppes T, Calabrese JR.
J Clin Psychiatry. 2005;66 Suppl 5:40-8.
PMID: 16038601.
A European perspective on the Canadian guidelines for bipolar disorder.
Vieta E, Nolen WA, Grunze H, Licht RW, Goodwin G.
Bipolar Disord. 2005;7 Suppl 3:73-6.
PMID: 15952959.
The Stanley Foundation Bipolar Network: results of the naturalistic follow-up study after 2.5 years of follow-up in the German centres.
Dittmann S, Biedermann NC, Grunze H, Hummel B, Schärer LO, Kleindienst N, Forsthoff A, Matzner N, Walser S, Walden J.
Neuropsychobiology. 2002;46 Suppl 1:2-9.
PMID: 12571425.
Life charts on a palmtop computer: first results of a feasibility study with an electronic diary for bipolar patients.
Schärer LO, Hartweg V, Valerius G, Graf M, Hoern M, Biedermann C, Walser S,
Boensch A, Dittmann S, Forsthoff A, Hummel B, Grunze H, Walden J.
Bipolar Disord. 2002;4 Suppl 1:107-8.
PMID: 12479693.
The Stanley Foundation Bipolar Network. I. Rationale and methods.
Post RM, Nolen WA, Kupka RW, Denicoff KD, Leverich GS, Keck PE Jr, McElroy
SL, Rush AJ, Suppes T, Altshuler LL, Frye MA, Grunze H, Walden J.
Br J Psychiatry Suppl. 2001 Jun;41:s169-76.
PMID: 11450179.
New insights into the mechanisms and sites of action of lamotrigine.
Langosch JM, Zhou XY, Grunze H, Walden J.
Neuropsychobiology. 2000;42 Suppl 1:26-7.
PMID: 11093067.
Treatment of acute mania with topiramate (Letter)
Normann C, Langosch J, Schaerer LO, Grunze H, Walden J.
Am J Psychiatry. 1999 Dec;156(12):2014.
PMID: 10588422.
H. Grunze: Untersuchungen an Adsorptionsfilmen zum Grenzflachenverhalten der Hamoglobinkomponente CTT IV von Chironomus thummi thummi in der Luft! Wasser- Grenzschicht mit einem Wilhelmy- Filmwaagesystem. Dissertation , Aachen 1989
J.Walden, H.Grunze: Bipolare Affektive Störungen- Ursachen und Behandlung. G. Thieme Verlag, Stuttgart. 1.Auflage: 1998, 2.Auflage: 2000, 3.Auflage 2003, 4.Auflage 2006, 5.Auflage 2009
H.Grunze, J.Walden: Die bipolaren Störungen (Manisch-depressive Erkrankungen): Ratgeber für Betroffene und ihre Angehörigen. G.Thieme Verlag, Stuttgart, 2003
R.Geislinger, H.Grunze: Bipolare Störungen- Ratgeber für Betroffene und Angehörige. DGBS Eigenverlag, Hamburg, 2002
H.Grunze, J.Walden: Valproat bei manisch-depressiven (bipolaren) Erkrankungen. G.Thieme Verlag, Stuttgart, 1.Auflage: 2000 , 2. Überarbeitete Auflage: 2004
J.Walden, H.Grunze: Bipolar Affective Disorder- Etiology and Treatment. G.Thieme Verlag, Stuttgart, 1.Auflage 2000, 2.Auflage 2004
J.Walden, E.J.Speckmann, D.Bingmann, U.Altrup, G.Eikmeier, H.Grunze, M.Gastpar: Neurophysiologische Aspekte der Wirkung von Carbamazepin. In: Neue Aspekte zur Diagnostik und Therapie affektiver Störungen. Hrsg. H.P.Wunderlich, W.Zuckschwerdt Verlag, München-Bern-Wien-San Franzisco, 1991,pp 14-26
H.Grunze,J.Walden,D.Bingmann,M.Berger: Calcium antagonism as a possible common mechanism of carbamazepine effects in epilepsy and psychiatric disorders, In: Proceedings of the Second International Conference on refractory Depression (Amsterdam 1992). Hrsg. J.Zohar,S.P.Roose, W.A.Nolen. J.Wiley &Sons, London 1992
J.Walden, D.Van Calker, J.von Wegerer, H.Grunze: Bedeutung des Calciumantagonismus in der Therapie der Epilepsien und affektiven Störungen. In: Aktuelle Perspektiven der Biologischen Psychiatrie. Hrsg. H.J.Möller, F.Müller-Spahn, G.Kurtz, Springer Verlag, Wien -New York, 1996,pp 797-800
H.Grunze, C.Kammerer: Störungen der glutamatergen Aktivierung limbisch-kortikaler Interneurone- ein zelluläres Psychosemodell ? In: Schizophrenie- Moderne Konzepte zu Diagnostik, Pathogenese und Therapie. Hrsg. H.J.Möller, N.Müller. Springer Verlag, Wien-New York, 1998, pp127-142
J.Walden,C.Normann,J.Langosch,M.Berger, H.Grunze: Bedeutung der Antiepileptika in der psychiatrischen Therapie. In: Spektrum psychiatrischer Arbeit. Hrsg. K.Peter Springer Verlag Wien-New York, 2000,pp 67-74
H.Grunze: Medikamentöse Therapie der Manie. In: Therapie psychischer Erkrankungen, Hrsg. H.J.Möller, G.Thieme Verlag, Stuttgart-New York,1999, pp 321-334; 3 . vollständig überarbeitete Auflage 2006, pp 351-363
H.J.Möller, H.Grunze: Antidepressant treatment of bipolar depression. In: Bipolar disorders-100 years after manic depressive insanity. Hrsg. A.Marneros, J.Angst. Kluwer Academic Publishers, Dordrecht, 2000, pp 387-404
H.J. Möller, H.Grunze: Erhaltungstherapie/Rezidivprophylaxe mit Antidepressiva. In: Neuro Psychopharmaka Band 3: Antidepressiva, Phasenprophylaktika und Stimmungsstabilisierer. 2. Neubearbeitete Auflage. Hrsg. P.Riederer, G.Laux, W. Pöldinger. Springer, Wien-New York 2002, pp 651-661
J.Walden, H.Grunze: Carbamazepin/Valproat: 13.2.Pharmakologie, 13.3. Neurobiochemie, Wirkmechanismus, 13.4. Klinik. In: Neuro Psychopharmaka Band 3: Antidepressiva, Phasenprophylaktika und Stimmungsstabilisierer. 2. Neubearbeitete Auflage. Hrsg. P.Riederer, G.Laux, W. Pöldinger. Springer, Wien-New York 2002, pp 866-895
H.Grunze, J.Walden: Exkurs: Potentielle neue Behandlungsmöglichkeiten bipolarer affektiver Störungen. In: Neuro Psychopharmaka Band 3: Antidepressiva, Phasenprophylaktika und Stimmungsstabilisierer. 2. Neubearbeitete Auflage. Hrsg. P.Riederer, G.Laux, W. Pöldinger. Springer, Wien-New York 2002, pp 896- 902
J.Walden, C.Normann, J.Langosch, A.Erfurth, H.Grunze: Valproinsäure in der Behandlung des manischen Syndroms und in der Prophylaxe bipolarer affektiver Störungen. In: Valproinsäure. Pharmakologie,Klinischer Einsatz, Nebenwirkungen und Therapierichtlinien, 2.Auflage. Hrsg. G.Krämer, J.Walden. Springer Verlag, Berlin-Heidelberg,2002, pp 248-255
A.Erfurth, H.Grunze, J.Walden: Valproinsäure zur Behandlung von „rapid cycling“ und dysphorischer Manie. In: Valproinsäure. Pharmakologie, Klinischer Einsatz, Nebenwirkungen und Therapierichtlinien, 2.Auflage. Hrsg. G.Krämer, J.Walden. Springer Verlag, Berlin-Heidelberg,2002 , pp 256-263
H.Grunze, A.Erfurth, B.Amann, J.Walden: Intravenöse Valproinsäure-Behandlung bei bipolaren Störungen. In: Valproinsäure. Pharmakologie,Klinischer Einsatz, Nebenwirkungen und Therapierichtlinien, 2.Auflage. Hrsg. G.Krämer, J.Walden. Springer Verlag, Berlin-Heidelberg, 2002,pp 264-274
H.Grunze, B.Amann, J.Walden: How might anticonvulsant drugs work in bipolar affective disorder? In: Seizures, Affective Disorders and Anticonvulsant Drugs. Hrsg. M.Trimble, B.Schmitz. Clarius Press, Guildford 2002, pp 117- 130
J.Walden, H. Grunze: New anticonvulsants in Bipolar Disorder: Lamotrigine, Gabapentin, Topiramate. In: Seizures, Affective Disorders and Anticonvulsant Drugs. Hrsg. M.Trimble, B.Schmitz. Clarius Press, Guildford 2002, pp 131-142
H.Grunze: The search for the Holy Grail- The ideal mood stabilizer: Fiction or Future. In: Bipolar Disorder. WPA Series Evidence and Experience in Psychiatry. Hrsg. M.Maj, H.S.Akiskal, J.J.Lopez-Ibor, N.Sartorius. Wiley, Chichester 2002, pp 229-232
H.Grunze, M.Dobmeier: Modul Therapie akuter Episoden. In: Weissbuch bipolare Störungen in Deutschland. Hrsg. Deutsche Gesellschaft für Bipolare Störungen e.V. Eigenverlag 2002, pp 57-66; 2.Auflage 2003, pp 89-130. 3.Auflage 2006, pp 161-206
H.Grunze: Bipolare Störungen. In: Psychotische Störungen. Hrsg. P.Falkai, F.G. Pajonk. G.Thieme Verlag, Stuttgart, 2003, pp 65-78.
H.J.Möller, M.Schmauss, H.Grunze: Biologische Behandlungsmethoden. In: Das Neue Handbuch der bipolaren und Depressiven Erkrankungen . Hrsg. A.Marneros. G.Thieme Verlag, Stuttgart-New York 2004, pp 225- 267
H.Grunze, A.Rohde, A.Marneros: Biologische Grundlagen. In: Das Neue Handbuch der bipolaren und Depressiven Erkrankungen . Hrsg. A.Marneros. G.Thieme Verlag, Stuttgart-New York 2004, pp 387-402
H.Grunze, J.Scharfetter: Elektrokonvulsionstherapie der manischen Episode im Rahmen einer bipolaren affektiven Störung. In: Elektrokunvulsionstherpie-klinische und wissenschaftliche Aspekte. Hrsg. T.C.Baghai, R.Frey,S.Kasper, H.J.Möller.Springer, Wien-New York, 2004, pp 394-405
H.J.Möller, H.Grunze: Is there a role for Typical Neuroleptics in bipolar disorder ? In: Handbook of Bipolar disorder. Hrsg. S.Kasper, R .M. Hirschfeld.Taylor& Francis, New York- London 2005, pp331- 338
H.Grunze: Toward an Integrated view: Algorithms in Bipolar disorder. In: Handbook of Bipolar disorder. Hrsg. S.Kasper, R .M. Hirschfeld.Taylor& Francis, New York- London 2005, pp 435-446
H.Grunze, J.Walden: Biological aspects of rapid-cycling and mixed states. In: Bipolar Disorders- Mixed states,Rapid cycling and atypical forms. Hrsg. A.Marneros,F.Goodwin. Cambridge University Press, New York, 2005, pp311-323
H.Grunze: Carbamazepine, Other Anticonvulsants and Augmenting Agents. In: Bipolar Psychopharmacology-Caring for the patient. Hrsg.H.S. Akiskal, M.Tohen. John Wiley & Sons, Chichester, 1.Auflage 2005, pp 63-84: 2.Auflage: 2011, pp 61-78
H.Grunze: Quetiapin in der Langzeitherapie bipolarer Störungen. In: Das Quetiapin-Dossier. Pharmakologie,Indikationen, therapeutische Erfahrungen.Hrsg. H.J. Möller. Schattauer Verlag, Stuttgart, 2005, pp 121-130
F.Seemüller, H.Grunze: Antikonvulsiva. In: Akute und therapieresistente Depressionen, 2.Auflage Hrsg. M.Bauer, A.Berghöfer, M.Adli. Springer Verlag, Heidelberg ,2005,pp273-284
J.Walden , H.Grunze: Optionen der Langzeittherapie bipolarer Verläufe. In: Handbuch Bipolare Störungen, Hrsb. H.J.Assion, W. Vollmöller. Verlag W.Kohlhammer, Stuttgart 2006, pp 154-159
H.Grunze,A. Forsthoff, C.Born: Polypharmazie in der Behandlung bipolarer Störungen. In: Polypharmazie in der Behandlung psychischer Erkrankungen. Hrsg. T.Messer, M.Schmauss. Springer Verlag, Wien New York, 2006, pp 81- 102. 2.Auflage 2009, pp 95-118. 3.Auflage 2016, pp 85-113
Beiträge im „Therapielexikon Psychiatrie, Psychosomatik & Psychotherapie“
A.Forsthoff,H.Grunze: Antiepileptika. In:Therapielexikon Psychiatrie, Psychosomatik & Psychotherapie. Hrsg. M.Zaudig, R.D. Trautmann.Springer Verlag Berlin-Heidelberg 2006, pp 69-70
A.Forsthoff, H.Grunze: Lamotrigin. In:Therapielexikon Psychiatrie, Psychosomatik & Psychotherapie. Hrsg. M.Zaudig, R.D. Trautmann.Springer Verlag Berlin-Heidelberg 2006, pp 427-428
A.Forsthoff, H.Grunze: Lichttherapie. In:Therapielexikon Psychiatrie, Psychosomatik & Psychotherapie. Hrsg. M.Zaudig, R.D. Trautmann.Springer Verlag Berlin-Heidelberg 2006, pp 438-439
A.Forsthoff, H.Grunze: Phasenprophylaxe. In:Therapielexikon Psychiatrie, Psychosomatik & Psychotherapie. Hrsg. M.Zaudig, R.D. Trautmann.Springer Verlag Berlin-Heidelberg 2006, pp 568-569
A.Forsthoff, H.Grunze: Rapid cycling. In:Therapielexikon Psychiatrie, Psychosomatik & Psychotherapie. Hrsg. M.Zaudig, R.D. Trautmann.Springer Verlag Berlin-Heidelberg 2006, pp 629-631
A.Forsthoff, H.Grunze: Rückfallverhütung. In:Therapielexikon Psychiatrie, Psychosomatik & Psychotherapie. Hrsg. M.Zaudig, R.D. Trautmann.Springer Verlag Berlin-Heidelberg 2006, pp 657
A.Forsthoff, H.Grunze: Selektive Serotonin Wiederaufnahmehemmer (SSRI). In:Therapielexikon Psychiatrie, Psychosomatik & Psychotherapie. Hrsg. M.Zaudig, R.D. Trautmann.Springer Verlag Berlin-Heidelberg 2006, pp 704-705
A.Forsthoff, H.Grunze: Serotonin-Noradrenalin-Wiederaufnahmehemmer (SNRI). In:Therapielexikon Psychiatrie, Psychosomatik & Psychotherapie. Hrsg. M.Zaudig, R.D. Trautmann.Springer Verlag Berlin-Heidelberg 2006, pp 709-710
A.Forsthoff, H.Grunze: Valproinsäure. In:Therapielexikon Psychiatrie, Psychosomatik & Psychotherapie. Hrsg. M.Zaudig, R.D. Trautmann.Springer Verlag Berlin-Heidelberg 2006, pp 812-814
H.Grunze, A.Forsthoff: Medikamente zur Behandlung bipolarer affektiver Störungen. In: Handbuch der Psychopharmakotherapie. Hrsg. F.Holsboer, G.Gründer, O.Benkert.Springer Verlag, Berlin-Heidelberg, 2008, pp 555-590
H.Grunze,C. Schüle, D.Casey, T.C. Baghai: Mood Disorders: Depression. In : Psychiatry, Third Edition, Hrsg. A.Tasman,J.Kay, J.A.Lieberman.M.B.First.M.Maj. Wiley-Blackwell, Chichester 2008, pp 1283- 1331
H.Grunze: The treatment of mania. In: Practical management of bipolar Disorder. Hrsg. A.H.Young,I.N.Ferrier, E.E.Michalak. Cambridge University Press, 2010, pp 10-23
H.Grunze: Bipolar Disorder. In: McGraw-Hill Yearbook of Science & Technology 2010. Hrsg. M.Licker et al. McGraw-Hill, New York, 2010, pp 48-50
H.Grunze, M.Bauer: Medikamente zur Behandlung bipolarer Störungen. In: Handbuch der Psychopharmakotherapie, 2. Auflage. Hrsg. G.Gründer, O.Benkert.Springer Verlag, Berlin-Heidelberg, 2012, pp 629-658
H.Grunze, J.Walden: Optionen der Langzeittherapie bipolarer Verläufe. In: H.J.Assion, P.Brieger, M.Bauer: Bipolare Störungen. Das Praxishandbuch. Verlag W.Kohlhammer, Stuttgart 2013, pp 167-175
H.Grunze: Chapter 14: The role of polypharmacy in Bipolar Disorder treatment guidelines. In: Polypharmacy in psychiatry practice, Vol II. , Hrsg. M.Ritsner. Springer Verlag, New York, 2013, pp 275-287
H. Grunze: Chapter 40. Bipolar Disorder. In: Zigmond MJ, Rowland LP, Coyle JT, eds. Neurobiology of Brain Disorders: Biological Basis of Neurological and Psychiatric Disorders. Academic Press; 2015, pp 655–673
M.Soyka, H.Grunze: Pharmacotherapy and dual disorders .In: Co-occurring addictive and psychiatric disorders: a practice based handbook on dual disorders within the European healthcare context. Hrsg. G.Dom, F.Moggi. Springer Verlag, New York, 2015, pp279-306
K. Gao, R.Wu, H. Grunze, JR Calabrese: Chapter 22. Pharmacological Treatment of Acute Bipolar Depression. In: Bipolar Disorder: Millenium Update. Hrsg. A.Yildiz, P.Ruiz., C.Nemeroff. Oxford University Press, New York, 2015, pp281-298
R.Wu, K. Gao, JR Calabrese, H. Grunze: Chapter 30. Treatment Induced Mood Instability: Treatment – Emergent Affective Switches and Cycle Acceleration. In: Bipolar Disorder: Millenium Update. Hrsg. A.Yildiz, C.Nemeroff, P.Ruiz. Oxford University Press, New York, 2015, pp417-434
W.A. Nolen, H. Grunze. Long-term treatment of mood disorders: follow-up of acute treatment phase studies versus continuation and maintenance phase studies, and enriched versus non-enriched designs. In: Clinical Trial Design Challenges In Mood Disorders. Hrsg. M.Tohen, C.Bowden, A.Nierenberg, J.Geddes. Elsevier, 2015, pp29-48
Schorb A, Grunze H: Agitation due to Substance Use, Abuse and Withdrawl. In Diagnosis and Management of Agitation . Eds: M. Zeller, K.Nordstrom, S.Wilson. Cambridge Press, 2016 in press
V.I.Reus, für die deutsche Ausgabe H.Grunze, H.J.Möller: Psychische Störungen. In: Harrisons Innere Medizin, 16th edition. Hrsg. Dt. Ausgabe M.Dietel, N.Suttorp, M.Zeitz. ABW-Verlag, Berlin, 2005, pp 2740-2754
H.Grunze: Bipolare Störungen. Fortbildungs-Medien-Akademie Psychiatrie. CME zertifiziere Fortbildungs –DVD. 2.Auflage, 2004
Maecenas vestibulum mollis diam. Pellentesque ut neque. Pellentesque habitant morbi tristique senectus et netus.
Proin sapien ipsum, porta a, auctor quis, euismod ut, mi. Aenean viverra rhoncus pede. Pellentesque morbi habitant morb.
Name des Unternehmens | ABC-Straße | 12345 Glückstadt
E-Mail: hallo@dein-unternehmen.de